These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 18353737

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone.
    Walsh JP, Ward LC, Stewart GO, Will RK, Criddle RA, Prince RL, Stuckey BG, Dhaliwal SS, Bhagat CI, Retallack RW, Kent GN, Drury PJ, Vasikaran S, Gutteridge DH.
    Bone; 2004 Apr; 34(4):747-54. PubMed ID: 15050907
    [Abstract] [Full Text] [Related]

  • 5. Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate.
    Hosking D, Lyles K, Brown JP, Fraser WD, Miller P, Curiel MD, Devogelaer JP, Hooper M, Su G, Zelenakas K, Pak J, Fashola T, Saidi Y, Eriksen EF, Reid IR.
    J Bone Miner Res; 2007 Jan; 22(1):142-8. PubMed ID: 17032148
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease.
    Reid IR, Miller P, Lyles K, Fraser W, Brown JP, Saidi Y, Mesenbrink P, Su G, Pak J, Zelenakas K, Luchi M, Richardson P, Hosking D.
    N Engl J Med; 2005 Sep 01; 353(9):898-908. PubMed ID: 16135834
    [Abstract] [Full Text] [Related]

  • 8. Once-yearly administered intravenous zoledronic acid for postmenopausal osteoporosis.
    Woodis CB.
    Ann Pharmacother; 2008 Jul 01; 42(7):1085-9. PubMed ID: 18505912
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Is a single infusion of zoledronic acid more effective than oral risedronate for the treatment of patients with Paget's disease?
    Krane SM.
    Nat Clin Pract Rheumatol; 2006 Apr 01; 2(4):186-7. PubMed ID: 16932682
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Bisphosphonate therapy for Paget's disease in a patient with hypoparathyroidism: profound hypocalcemia, rapid response, and prolonged remission.
    Stuckey BG, Lim EM, Kent GN, Ward LC, Gutteridge DH.
    J Bone Miner Res; 2001 Sep 01; 16(9):1719-23. PubMed ID: 11547843
    [Abstract] [Full Text] [Related]

  • 13. Bisphosphonate use in the treatment of Paget's disease of the bone: analysis of claims in a large database.
    Dolgitser M, Stern L, Katz LM, Doyle JJ, Omar M, Seton M, Kahler KH.
    Manag Care Interface; 2007 Feb 01; 20(2):33-40. PubMed ID: 17405580
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological therapy of Paget's and other metabolic bone diseases.
    Hosking D.
    Bone; 2006 Feb 01; 38(2 Suppl 2):S3-7. PubMed ID: 16406763
    [Abstract] [Full Text] [Related]

  • 15. Case report of implant placement in a patient with Paget's disease on bisphosphonate therapy.
    Pirih FQ, Zablotsky M, Cordell K, McCauley LK.
    J Mich Dent Assoc; 2009 May 01; 91(5):38-43. PubMed ID: 19537656
    [Abstract] [Full Text] [Related]

  • 16. Treatment of Paget's disease of bone with aminohydroxybutylidene bisphosphonate.
    O'Doherty DP, Bickerstaff DR, McCloskey EV, Hamdy NA, Beneton MN, Harris S, Mian M, Kanis JA.
    J Bone Miner Res; 1990 May 01; 5(5):483-91. PubMed ID: 2195845
    [Abstract] [Full Text] [Related]

  • 17. Management of Paget's disease of bone.
    Langston AL, Ralston SH.
    Rheumatology (Oxford); 2004 Aug 01; 43(8):955-9. PubMed ID: 15187244
    [Abstract] [Full Text] [Related]

  • 18. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
    Grewal VS, Fayans EP.
    Todays FDA; 2008 Aug 01; 20(8):38-41, 43-6. PubMed ID: 18767452
    [Abstract] [Full Text] [Related]

  • 19. Improved treatment of Paget's disease with dimethylaminohydroxypropylidene bisphosphonate.
    Schweitzer DH, Zwinderman AH, Vermeij P, Bijvoet OL, Papapoulos SE.
    J Bone Miner Res; 1993 Feb 01; 8(2):175-82. PubMed ID: 8442435
    [Abstract] [Full Text] [Related]

  • 20. Treatment with tiludronate has a similar effect to risedronate on Paget's disease activity assessed by bone markers and bone scintigraphy.
    Peris P, Alvarez L, Vidal S, Martínez MA, Monegal A, Guañabens N.
    Clin Exp Rheumatol; 2007 Feb 01; 25(2):206-10. PubMed ID: 17543143
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.